Who Owns MacroGenics Stock?
NASDAQ: MGNXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 77.63%
- Held by insiders
- 3.49%
- Institutional holders
- 173
- Institutions 77.6%
- Insiders 3.5%
- Public and other 18.9%
Who owns MacroGenics stock?
Institutional investors own about 77.6% of MacroGenics's shares, spread across 173 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 3.49% of MGNX.
The largest institutional holders are Armistice Capital, LLC (7.86%), Blackrock Inc. (7.35%) and Vanguard Capital Management LLC (4.17%). Together, the top 10 institutions control 45.1% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their MGNX positions and 5 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of MGNX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Armistice Capital, LLC | 5.01M | 7.86% | -16.7% |
| Blackrock Inc. | 4.68M | 7.35% | +302.3% |
| Vanguard Capital Management LLC | 2.66M | 4.17% | +0.1% |
| Renaissance Technologies, LLC | 2.63M | 4.13% | -11.2% |
| Acadian Asset Management. LLC | 2.54M | 3.99% | -0.1% |
| Bank of America Corporation | 2.49M | 3.91% | +3.6% |
| Two Sigma Investments, LP | 2.47M | 3.87% | -2.5% |
| Millennium Management Llc | 2.37M | 3.73% | -15.0% |
| Wasatch Advisors LP | 2.02M | 3.17% | +29.4% |
| RA Capital Management, L.P. | 1.86M | 2.93% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of MGNX
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.93M | 3.02% |
| iShares Trust-iShares Russell 2000 ETF | 1.54M | 2.41% |
| WASATCH FUNDS TRUST-Wasatch Ultra Growth Fund | 1.12M | 1.75% |
| WASATCH FUNDS TRUST-Wasatch Micro Cap Fund | 771.22K | 1.21% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 683.33K | 1.07% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 649.40K | 1.02% |
| VANGUARD HORIZON FUNDS-Vanguard Strategic Small-Cap Equity Fund | 551.03K | 0.87% |
| iShares Trust-iShares Russell 2000 Growth ETF | 516.97K | 0.81% |
| VANGUARD VARIABLE INSURANCE FUNDS-Small Company Growth Portfolio | 437.61K | 0.69% |
| Vanguard Explorer Fund | 421.51K | 0.66% |
Frequently asked questions
Who is the largest shareholder of MacroGenics?
Armistice Capital, LLC is the largest institutional shareholder of MGNX, owning 7.86% of shares outstanding (5.01M shares) as of its latest 13F filing.
What percentage of MacroGenics is owned by institutions?
Institutions own about 77.6% of MGNX shares and 80.4% of the public float.
How much of MacroGenics do insiders own?
Insiders, such as officers and directors, own about 3.49% of MGNX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.